- Home
- CFSB vs UNCY Comparison
CFSB vs UNCY Comparison
Compare CFSB & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CFSB
- UNCY
- Stock Information
- Founded
- CFSB 1889
- UNCY 2016
- Country
- CFSB United States
- UNCY United States
- Employees
- CFSB N/A
- UNCY N/A
- Industry
- CFSB Major Banks
- UNCY Biotechnology: Pharmaceutical Preparations
- Sector
- CFSB Finance
- UNCY Health Care
- Exchange
- CFSB Nasdaq
- UNCY Nasdaq
- Market Cap
- CFSB 92.5M
- UNCY 74.2M
- IPO Year
- CFSB N/A
- UNCY 2021
- Fundamental
- Price
- CFSB $14.14
- UNCY $4.62
- Analyst Decision
- CFSB
- UNCY Strong Buy
- Analyst Count
- CFSB 0
- UNCY 5
- Target Price
- CFSB N/A
- UNCY $55.20
- AVG Volume (30 Days)
- CFSB 3.4K
- UNCY 508.1K
- Earning Date
- CFSB 10-28-2025
- UNCY 11-12-2025
- Dividend Yield
- CFSB N/A
- UNCY N/A
- EPS Growth
- CFSB N/A
- UNCY N/A
- EPS
- CFSB N/A
- UNCY N/A
- Revenue
- CFSB $7,612,000.00
- UNCY N/A
- Revenue This Year
- CFSB N/A
- UNCY N/A
- Revenue Next Year
- CFSB N/A
- UNCY $4,481.14
- P/E Ratio
- CFSB N/A
- UNCY N/A
- Revenue Growth
- CFSB N/A
- UNCY N/A
- 52 Week Low
- CFSB $6.41
- UNCY $3.40
- 52 Week High
- CFSB $14.24
- UNCY $11.00
- Technical
- Relative Strength Index (RSI)
- CFSB 53.55
- UNCY 63.99
- Support Level
- CFSB $14.11
- UNCY $3.71
- Resistance Level
- CFSB $14.22
- UNCY $4.06
- Average True Range (ATR)
- CFSB 0.06
- UNCY 0.24
- MACD
- CFSB -0.01
- UNCY 0.09
- Stochastic Oscillator
- CFSB 62.50
- UNCY 83.49
About CFSB CFSB Bancorp Inc.
CFSB Bancorp Inc provides banking services. It offers a variety of financial services to individuals and small businesses through its offices in Quincy, Holbrook, and Weymouth. Its primary deposit products are savings, checking, and term certificate accounts, and its primary lending product is residential mortgage loans.The Company's loan portfolio includes residential real estate, commercial real estate, construction, and consumer loan segments. Residential real estate loans include classes for one- to four-family, multi-family, second mortgages and home equity lines of credit.
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.